Sign In

Login

Password

Forgot Password ? Sign Up

Statină (Romanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Statină" in Romanian language version.

refsWebsite
Global rank Romanian rank
30nih.gov
4th place
4th place
29doi.org
2nd place
3rd place
3nice.org.uk
3,258th place
1,726th place
1wiley.com
222nd place
251st place
1pfizer.com
low place
low place
1web.archive.org
1st place
1st place
1bmj.com
1,226th place
1,215th place
1ama-assn.org
3,257th place
2,330th place

ama-assn.org

jama.ama-assn.org

bmj.com

doi.org

  • Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S (). „Statins for the primary prevention of cardiovascular disease”. Cochrane Database Syst Rev. 1: CD004816. doi:10.1002/14651858.CD004816.pub5. PMID 23440795. 
  • Taylor, FC; Huffman, M; Ebrahim, S (). „Statin therapy for primary prevention of cardiovascular disease”. JAMA. 310 (22): 2451–2. doi:10.1001/jama.2013.281348. PMID 24276813. 
  • Taylor, FC; Huffman, M; Ebrahim, S (). „Statin therapy for primary prevention of cardiovascular disease”. JAMA. 310 (22): 2451–2. doi:10.1001/jama.2013.281348. PMID 24276813. 
  • Tonelli M, Lloyd A, Clement F, Conly J, Husereau D, Hemmelgarn B, Klarenbach S, McAlister FA, Wiebe N, Manns B (). „Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis”. CMAJ. 183 (16): E1189–202. doi:10.1503/cmaj.101280. PMC 3216447 Accesibil gratuit. PMID 21989464. 
  • Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB (). „Meta-analysis of statin effects in women versus men”. J. Am. Coll. Cardiol. 59 (6): 572–82. doi:10.1016/j.jacc.2011.09.067. PMID 22300691. 
  • Petretta M, Costanzo P, Perrone-Filardi P, Chiariello M (). „Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis”. Int. J. Cardiol. 138 (1): 25–31. doi:10.1016/j.ijcard.2008.08.001. PMID 18793814. 
  • Law MR, Wald NJ, Rudnicka AR (iunie 2003). „Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis”. BMJ. 326 (7404): 1423. doi:10.1136/bmj.326.7404.1423. PMC 162260 Accesibil gratuit. PMID 12829554. 
  • Naci H, Brugts J, Ades T (iulie 2013). „Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials”. Circ Cardiovasc Qual Outcomes. 6 (4): 390–9. doi:10.1161/CIRCOUTCOMES.111.000071. PMID 23838105. 
  • Bellosta, S; Corsini, A (). „Statin drug interactions and related adverse reactions”. Expert Opin Drug Saf. 11 (6): 933–46. doi:10.1517/14740338.2012.712959. PMID 22866966. 
  • Bellosta, S; Corsini, A (). „Statin drug interactions and related adverse reactions”. Expert Opin Drug Saf. 11 (6): 933–46. doi:10.1517/14740338.2012.712959. PMID 22866966. 
  • Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I (). „Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials”. Lancet. 375 (9716): 735–42. doi:10.1016/S0140-6736(09)61965-6. PMID 20167359. 
  • Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, DeMicco DA, Barter P, Cannon CP, Sabatine MS, Braunwald E, Kastelein JJ, de Lemos JA, Blazing MA, Pedersen TR, Tikkanen MJ, Sattar N, Ray KK (). „Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis”. JAMA. 305 (24): 2556–64. doi:10.1001/jama.2011.860. PMID 21693744. 
  • Jukema JW, Cannon CP, de Craen AJ, Westendorp RG, Trompet S (). „The controversies of statin therapy: weighing the evidence”. Journal of the American College of Cardiology. 60 (10): 875–81. doi:10.1016/j.jacc.2012.07.007. PMID 22902202. 
  • Rutishauser J (). „Statins in clinical medicine”. Swiss medical weekly. 141: w13310. doi:10.4414/smw.2011.13310. PMID 22101921. 
  • Alsheikh-Ali AA, Maddukuri PV, Han H, Karas RH (). „Effect of the Magnitude of Lipid Lowering on Risk of Elevated Liver Enzymes, Rhabdomyolysis, and Cancer: Insights from Large Randomized Statin Trials”. Journal of the American College of Cardiology. 50 (5): 409–418. doi:10.1016/j.jacc.2007.02.073. PMID 17662392. 
  • Dale KM, Coleman CI, Henyan NN, Kluger J, White CM (). „Statins and cancer risk: a meta-analysis”. JAMA. 295 (1): 74–80. doi:10.1001/jama.295.1.74. PMID 16391219. 
  • Alsheikh-Ali AA, Karas RH (martie 2009). „The relationship of statins to rhabdomyolysis, malignancy, and hepatic toxicity: evidence from clinical trials”. Current atherosclerosis reports. 11 (2): 100–4. doi:10.1007/s11883-009-0016-8. PMID 19228482. 
  • Singh S, Singh AG, Singh PP, Murad MH, Iyer PG (iunie 2013). „Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis”. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 11 (6): 620–9. doi:10.1016/j.cgh.2012.12.036. PMID 23357487. 
  • Liu Y, Tang W, Wang J, Xie L, Li T, He Y, Deng Y, Peng Q, Li S, Qin X (). „Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies”. Cancer causes & control : CCC. 25 (2): 237–49. doi:10.1007/s10552-013-0326-6. PMID 24265089. 
  • Wu XD, Zeng K, Xue FQ, Chen JH, Chen YQ (octombrie 2013). „Statins are associated with reduced risk of gastric cancer: a meta-analysis”. European journal of clinical pharmacology. 69 (10): 1855–60. doi:10.1007/s00228-013-1547-z. PMID 23748751. 
  • Singh PP, Singh S (iulie 2013). „Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis”. Annals of Oncology. 24 (7): 1721–30. doi:10.1093/annonc/mdt150. PMID 23599253. 
  • Pradelli D, Soranna D, Scotti L, Zambon A, Catapano A, Mancia G, La Vecchia C, Corrao G (mai 2013). „Statins and primary liver cancer: a meta-analysis of observational studies”. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 22 (3): 229–34. doi:10.1097/cej.0b013e328358761a. PMID 23010949. 
  • Zhang Y, Zang T (). „Association between statin usage and prostate cancer prevention: a refined meta-analysis based on literature from the years 2005–2010”. Urologia internationalis. 90 (3): 259–62. doi:10.1159/000341977. PMID 23052323. 
  • Bansal D, Undela K, D'Cruz S, Schifano F (). „Statin use and risk of prostate cancer: a meta-analysis of observational studies”. PLoS ONE. 7 (10): e46691. doi:10.1371/journal.pone.0046691. PMID 23049713. 
  • Tan M, Song X, Zhang G, Peng A, Li X, Li M, Liu Y, Wang C (). „Statins and the risk of lung cancer: a meta-analysis”. PLoS ONE. 8 (2): e57349. doi:10.1371/journal.pone.0057349. PMID 23468972. 
  • Zhang XL, Liu M, Qian J, Zheng JH, Zhang XP, Guo CC, Geng J, Peng B, Che JP, Wu Y (). „Statin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trials”. British Journal of Clinical Pharmacology. 77 (3): 458–465. doi:10.1111/bcp.12210. PMID 23879311. 
  • Undela K, Srikanth V, Bansal D (august 2012). „Statin use and risk of breast cancer: a meta-analysis of observational studies”. Breast cancer research and treatment. 135 (1): 261–9. doi:10.1007/s10549-012-2154-x. PMID 22806241. 
  • Cui X, Xie Y, Chen M, Li J, Liao X, Shen J, Shi M, Li W, Zheng H, Jiang B (iulie 2012). „Statin use and risk of pancreatic cancer: a meta-analysis”. Cancer causes & control : CCC. 23 (7): 1099–111. doi:10.1007/s10552-012-9979-9. PMID 22562222. 
  • Zhang XL, Geng J, Zhang XP, Peng B, Che JP, Yan Y, Wang GC, Xia SQ, Wu Y, Zheng JH (aprilie 2013). „Statin use and risk of bladder cancer: a meta-analysis”. Cancer causes & control : CCC. 24 (4): 769–76. doi:10.1007/s10552-013-0159-3. PMID 23361339. 

nice.org.uk

nih.gov

ncbi.nlm.nih.gov

  • „Lipid Modification - National Library of Medicine - PubMed Health”. 
  • Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S (). „Statins for the primary prevention of cardiovascular disease”. Cochrane Database Syst Rev. 1: CD004816. doi:10.1002/14651858.CD004816.pub5. PMID 23440795. 
  • Taylor, FC; Huffman, M; Ebrahim, S (). „Statin therapy for primary prevention of cardiovascular disease”. JAMA. 310 (22): 2451–2. doi:10.1001/jama.2013.281348. PMID 24276813. 
  • Taylor, FC; Huffman, M; Ebrahim, S (). „Statin therapy for primary prevention of cardiovascular disease”. JAMA. 310 (22): 2451–2. doi:10.1001/jama.2013.281348. PMID 24276813. 
  • Tonelli M, Lloyd A, Clement F, Conly J, Husereau D, Hemmelgarn B, Klarenbach S, McAlister FA, Wiebe N, Manns B (). „Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis”. CMAJ. 183 (16): E1189–202. doi:10.1503/cmaj.101280. PMC 3216447 Accesibil gratuit. PMID 21989464. 
  • Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB (). „Meta-analysis of statin effects in women versus men”. J. Am. Coll. Cardiol. 59 (6): 572–82. doi:10.1016/j.jacc.2011.09.067. PMID 22300691. 
  • Petretta M, Costanzo P, Perrone-Filardi P, Chiariello M (). „Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis”. Int. J. Cardiol. 138 (1): 25–31. doi:10.1016/j.ijcard.2008.08.001. PMID 18793814. 
  • Law MR, Wald NJ, Rudnicka AR (iunie 2003). „Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis”. BMJ. 326 (7404): 1423. doi:10.1136/bmj.326.7404.1423. PMC 162260 Accesibil gratuit. PMID 12829554. 
  • Naci H, Brugts J, Ades T (iulie 2013). „Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials”. Circ Cardiovasc Qual Outcomes. 6 (4): 390–9. doi:10.1161/CIRCOUTCOMES.111.000071. PMID 23838105. 
  • Bellosta, S; Corsini, A (). „Statin drug interactions and related adverse reactions”. Expert Opin Drug Saf. 11 (6): 933–46. doi:10.1517/14740338.2012.712959. PMID 22866966. 
  • Bellosta, S; Corsini, A (). „Statin drug interactions and related adverse reactions”. Expert Opin Drug Saf. 11 (6): 933–46. doi:10.1517/14740338.2012.712959. PMID 22866966. 
  • Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I (). „Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials”. Lancet. 375 (9716): 735–42. doi:10.1016/S0140-6736(09)61965-6. PMID 20167359. 
  • Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, DeMicco DA, Barter P, Cannon CP, Sabatine MS, Braunwald E, Kastelein JJ, de Lemos JA, Blazing MA, Pedersen TR, Tikkanen MJ, Sattar N, Ray KK (). „Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis”. JAMA. 305 (24): 2556–64. doi:10.1001/jama.2011.860. PMID 21693744. 
  • Jukema JW, Cannon CP, de Craen AJ, Westendorp RG, Trompet S (). „The controversies of statin therapy: weighing the evidence”. Journal of the American College of Cardiology. 60 (10): 875–81. doi:10.1016/j.jacc.2012.07.007. PMID 22902202. 
  • Rutishauser J (). „Statins in clinical medicine”. Swiss medical weekly. 141: w13310. doi:10.4414/smw.2011.13310. PMID 22101921. 
  • Alsheikh-Ali AA, Maddukuri PV, Han H, Karas RH (). „Effect of the Magnitude of Lipid Lowering on Risk of Elevated Liver Enzymes, Rhabdomyolysis, and Cancer: Insights from Large Randomized Statin Trials”. Journal of the American College of Cardiology. 50 (5): 409–418. doi:10.1016/j.jacc.2007.02.073. PMID 17662392. 
  • Dale KM, Coleman CI, Henyan NN, Kluger J, White CM (). „Statins and cancer risk: a meta-analysis”. JAMA. 295 (1): 74–80. doi:10.1001/jama.295.1.74. PMID 16391219. 
  • Alsheikh-Ali AA, Karas RH (martie 2009). „The relationship of statins to rhabdomyolysis, malignancy, and hepatic toxicity: evidence from clinical trials”. Current atherosclerosis reports. 11 (2): 100–4. doi:10.1007/s11883-009-0016-8. PMID 19228482. 
  • Singh S, Singh AG, Singh PP, Murad MH, Iyer PG (iunie 2013). „Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis”. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 11 (6): 620–9. doi:10.1016/j.cgh.2012.12.036. PMID 23357487. 
  • Liu Y, Tang W, Wang J, Xie L, Li T, He Y, Deng Y, Peng Q, Li S, Qin X (). „Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies”. Cancer causes & control : CCC. 25 (2): 237–49. doi:10.1007/s10552-013-0326-6. PMID 24265089. 
  • Wu XD, Zeng K, Xue FQ, Chen JH, Chen YQ (octombrie 2013). „Statins are associated with reduced risk of gastric cancer: a meta-analysis”. European journal of clinical pharmacology. 69 (10): 1855–60. doi:10.1007/s00228-013-1547-z. PMID 23748751. 
  • Singh PP, Singh S (iulie 2013). „Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis”. Annals of Oncology. 24 (7): 1721–30. doi:10.1093/annonc/mdt150. PMID 23599253. 
  • Pradelli D, Soranna D, Scotti L, Zambon A, Catapano A, Mancia G, La Vecchia C, Corrao G (mai 2013). „Statins and primary liver cancer: a meta-analysis of observational studies”. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 22 (3): 229–34. doi:10.1097/cej.0b013e328358761a. PMID 23010949. 
  • Zhang Y, Zang T (). „Association between statin usage and prostate cancer prevention: a refined meta-analysis based on literature from the years 2005–2010”. Urologia internationalis. 90 (3): 259–62. doi:10.1159/000341977. PMID 23052323. 
  • Bansal D, Undela K, D'Cruz S, Schifano F (). „Statin use and risk of prostate cancer: a meta-analysis of observational studies”. PLoS ONE. 7 (10): e46691. doi:10.1371/journal.pone.0046691. PMID 23049713. 
  • Tan M, Song X, Zhang G, Peng A, Li X, Li M, Liu Y, Wang C (). „Statins and the risk of lung cancer: a meta-analysis”. PLoS ONE. 8 (2): e57349. doi:10.1371/journal.pone.0057349. PMID 23468972. 
  • Zhang XL, Liu M, Qian J, Zheng JH, Zhang XP, Guo CC, Geng J, Peng B, Che JP, Wu Y (). „Statin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trials”. British Journal of Clinical Pharmacology. 77 (3): 458–465. doi:10.1111/bcp.12210. PMID 23879311. 
  • Undela K, Srikanth V, Bansal D (august 2012). „Statin use and risk of breast cancer: a meta-analysis of observational studies”. Breast cancer research and treatment. 135 (1): 261–9. doi:10.1007/s10549-012-2154-x. PMID 22806241. 
  • Cui X, Xie Y, Chen M, Li J, Liao X, Shen J, Shi M, Li W, Zheng H, Jiang B (iulie 2012). „Statin use and risk of pancreatic cancer: a meta-analysis”. Cancer causes & control : CCC. 23 (7): 1099–111. doi:10.1007/s10552-012-9979-9. PMID 22562222. 
  • Zhang XL, Geng J, Zhang XP, Peng B, Che JP, Yan Y, Wang GC, Xia SQ, Wu Y, Zheng JH (aprilie 2013). „Statin use and risk of bladder cancer: a meta-analysis”. Cancer causes & control : CCC. 24 (4): 769–76. doi:10.1007/s10552-013-0159-3. PMID 23361339. 

pfizer.com

media.pfizer.com

web.archive.org

wiley.com

onlinelibrary.wiley.com